Toque H A, Teixeira C E, Priviero F B M, Morganti R P, Antunes E, De Nucci G
Department of Pharmacology, Faculty of Medical Sciences, UNICAMP, Campinas, Brazil.
Br J Pharmacol. 2008 Jun;154(4):787-96. doi: 10.1038/bjp.2008.141. Epub 2008 Apr 21.
Phosphodiesterase type-5 (PDE5) inhibitors constitute a novel and important therapeutic option for the treatment of pulmonary hypertension. The effects of the PDE5 inhibitors sildenafil, tadalafil and vardenafil on rabbit isolated pulmonary artery ring preparations and on intracellular Ca2+ concentration of thrombin-stimulated human platelets were investigated.
Rabbit pulmonary artery rings were mounted in 10 mL organ bath containing Krebs solution. Tissues were connected to force-displacement transducers, and changes in isometric force were recorded. Ca2+ flux in human washed platelets was measured.
Sildenafil, tadalafil and vardenafil (0.0001-10 microM) concentration-dependently relaxed endothelium-intact and endothelium-denuded pulmonary artery rings. Endothelium denudation caused rightward shifts in the concentration-response curves to sildenafil, tadalafil and vardenafil (9-, 12- and 123-fold, respectively). Incubation with N(omega)-nitro-L-arginine methyl ester (100 microM) or ODQ (1H-[1,2,4] oxadiazolo [4,3,-a]quinoxalin-1-one) (10 microM) caused similar reductions of PDE5-induced vasorelaxations in intact rings. Sildenafil and tadalafil did not affect the phenylephrine-induced contractions, whereas vardenafil reduced the maximal responses, and shifted the phenylephrine-induced contraction curves to the right in endothelium-denuded rings (5- and 19-fold for 1 and 10 microM, respectively). Vardenafil (but neither sildenafil nor tadalafil) caused a marked rightward shift and a decrease of maximal contractile response to CaCl2. Vardenafil, but neither sildenafil nor tadalafil, significantly reduced the Ca2+ mobilization and Ca2+ influx in thrombin-stimulated washed platelets.
Our results indicate that vardenafil, in contrast to sildenafil or tadalafil, also blocked Ca2+ fluxes, thus enhancing its vasorelaxation of the pulmonary artery.
5型磷酸二酯酶(PDE5)抑制剂是治疗肺动脉高压的一种新型且重要的治疗选择。研究了PDE5抑制剂西地那非、他达拉非和伐地那非对兔离体肺动脉环标本以及对凝血酶刺激的人血小板细胞内钙离子浓度的影响。
将兔肺动脉环置于含有 Krebs 溶液的10 mL 器官浴槽中。组织连接到力-位移换能器,记录等长力的变化。测定人洗涤血小板中的钙离子通量。
西地那非、他达拉非和伐地那非(0.0001 - 10 μM)浓度依赖性地舒张内皮完整和内皮剥脱的肺动脉环。内皮剥脱使西地那非、他达拉非和伐地那非的浓度-反应曲线分别向右移动9倍、12倍和123倍。用N(ω)-硝基-L-精氨酸甲酯(100 μM)或ODQ(1H-[1,2,4]恶二唑并[4,3,-a]喹喔啉-1-酮)(10 μM)孵育导致完整环中PDE5诱导的血管舒张有类似程度的降低。西地那非和他达拉非不影响去氧肾上腺素诱导的收缩,而伐地那非降低最大反应,并使内皮剥脱环中去氧肾上腺素诱导的收缩曲线向右移动(1 μM和10 μM分别为5倍和19倍)。伐地那非(但西地那非和他达拉非均无此作用)使对氯化钙的最大收缩反应明显向右移动并降低。伐地那非,但不是西地那非和他达拉非,显著减少凝血酶刺激的洗涤血小板中的钙离子动员和钙离子内流。
我们的结果表明,与西地那非或他达拉非相比,伐地那非还阻断钙离子通量,从而增强其对肺动脉的血管舒张作用。